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Proximal tubular cytochrome c efflux: Determinant, and poten-
tial marker, of mitochondrial injury.
Background. Cytochrome c (cyt c) is released from mitochon-
dria after tissue injury, but little is known of its subsequent fate.
This study was undertaken to ascertain: (1) does cyt c readily
gain access to the extracellular space; (2) if so, what are some
determinants of this process; and (3) might cyt c release be a
potentially useful marker of in vivo tissue damage.
Methods. Isolated mouse proximal tubules (PT) were sub-
jected to site 1 (rotenone; Rot), site 2 (antimycin A, AA), or
site 3 (hypoxic) respiratory chain blockade (± 2 mmol/L glycine,
to prevent plasma membrane disruption/cell death). Alterna-
tively, oxidant injury was imposed (Fe2+ or cholesterol oxidase).
Extra- and intracellular cyt c levels were quantified by Western
blot. Plasma or urine cyt c levels were also determined after
rhabdomyolysis or ischemic acute renal failure (ARF) (in mice),
or clinical ARF.
Results. AA, Rot, and hypoxia caused variable degrees of PT
cyt c release (AA  rot ≈ hypoxia), but at most, <20% of total
cell content was involved. In contrast, Fe2+ evoked ∼65% cyt
c efflux, and cholesterol oxidation caused ∼100% cyt c release.
Glycine did not block cyt c efflux, dissociating this process from
plasma membrane disruption/necrotic cell death. After rhab-
domyolysis, plasma cyt c levels rose and correlated with the
severity of ARF (r, 0.93 vs. BUNs). Cyt c was detected in urine
after both experimental and clinical ARF.
Conclusion. Cell cyt c release is dependent on the site and
the type of mitochondrial injury sustained. Oxidative injury, in
general, and cholesterol oxidation, in particular, seem partic-
ularly relevant in this regard. After mitochondrial release, cyt
c traverses plasma membranes, eventuating in the extracellu-
lar space. The data suggest that plasma and/or urine cyt c ap-
pearance might function as a clinically useful in vivo marker of
mitochondrial stress and the tissue injury sustained.
Cytochrome c (cyt c) is a porphyrin iron-containing
protein that is part of the mitochondrial respiratory chain.
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Recent interest has focused on its role as a potential in-
ducer of the intrinsic apoptotic pathway (e.g., references
[1–5]). In response to a variety of pathophysiologic stim-
uli, cyt c is released from its normal intra-mitochondrial
location(s), it traverses the outer mitochondrial mem-
brane, and reaches the cytosol. This process, which may
occur in part via mitochondrial permeability pore tran-
sition, can be retarded, or enhanced, by antiapoptotic
(Bcl2, Bcl-xL), or proapoptotic (Bax, Bad, Bak, Bid)
proteins, respectively [6–10]. Upon reaching the cytosol,
and in the presence of deoxyadenosine triphosphate, cyt
c binds to Apaf-1 (apoptotic protease-activation factor-
1), a process that leads to caspase 9 recruitment [1–5].
The resulting cyt-c/Apaf-2/caspase 9 complex (the so
called ‘apoptosome’) can then activate ‘downstream’
effector caspases (-3, -7), culminating in cellular pro-
tein degradation, and ultimately, apoptotic cell death
[1–5].
In a recent series of experiments from this laboratory,
we noted that exposing isolated mouse proximal tubule
segments to a radiographic contrast agent (ioversol) re-
sulted in the rapid appearance of cyt c within the tubule-
suspending medium, as detected by Western blotting [11].
This occurred in the setting of minimal, if any, cellular lac-
tate dehydrogenase (LDH) release. This indicated that
the observed cyt c loss did not simply reflect plasma mem-
brane disruption, a marker of necrotic cell death. Rather,
cyt c’s extracellular appearance corresponded with func-
tional mitochondrial impairment, as denoted by modest
declines in cellular ATP. In composite, these observations
suggested that, in renal tubules, sublethal mitochondrial
dysfunction may be detected by cyt c release into the ex-
tracellular space.
If these in vitro results were to have an in vivo cor-
relate, mitochondrial injury would be expected to cause
cellular cyt c leakage, first into the interstitial fluid com-
partment, and ultimately into plasma. If so, then plasma
cyt c appearance could serve as a marker of in vivo mito-
chondrial injury, or possibly apoptotic death. In support
of this concept are recent observations from Renz et al
[12], who detected cyt c in plasma after chemotherapy of
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hematologic malignancies. However, whether this finding
is specific for chemotherapy-induced tumor cell apopto-
sis, or whether necrotic injury to otherwise normal tissues,
such as proximal tubules, might induce a similar result re-
mains unknown.
Given these considerations, the present study had the
following specific aims: (1) to test whether plasma cyt c
release might serve as either a qualitative or quantita-
tive marker of acute in vivo tissue damage; (2) to ascer-
tain whether cyt c can appear in urine, reflecting either
glomerular filtration or tubular cell release; and (3) to de-
termine some of the cellular determinants of cyt c release,
using isolated proximal renal tubules as a representative
test system. The results of these experiments form the
basis of this report.
METHODS
Plasma cytochrome c as a potential marker
of glycerol-induced rhabdomyolysis
The injection of hypertonic glycerol into muscle in-
duces a well-defined syndrome of localized muscle necro-
sis, myoglobin release, mild hemolysis, decreased cardiac
output, and renal vasoconstriction, which culminate in a
combined form of toxic and ischemic acute renal failure
(ARF) [13–15]. As such, this model recapitulates many
of the pathogenic features of severe trauma and its re-
sultant ARF. The following experiment was undertaken
to ascertain whether this form of injury culminates in the
appearance of cyt c in plasma, and if so, does this process
correlate with the extent of tissue damage. Six mice
were briefly anesthetized with isoflurane and then in-
jected with 10 mL/kg of 50% glycerol, administered in
equally divided doses into the upper hind limbs [14].
The mice were then allowed to recover from anesthe-
sia, allowed free food and water access. Approximately
18 hours later, the mice were deeply anesthetized with
pentobarbital (∼5 mg, i.p. injection), the inferior vena
cava was exposed through a midline abdominal inci-
sion, and the mice were killed by phlebotomy from
the inferior vena cava. Five mice treated in an identi-
cal fashion but without glycerol injection provided con-
trol plasma samples. All plasma was assayed for blood
urea nitrogen (BUN) concentrations as a marker of
the severity of rhabdomyolysis-induced ARF. Plasma
samples were also analyzed for cyt c using Western blot-
ting with enhanced chemiluminescence (ECL) detec-
tion, as discussed below. Ten lL plasma samples were
applied. In order to confirm the specificity of the re-
action for circulating cyt c, the assay was run while
omitting the primary, but not the secondary (detec-
tion), antibody. The amount of cyt c present per sample
was gauged semiquantitatively by densitometric analysis
[11].
Relationship between the severity of glycerol-induced
ARF and cyt c levels
The following experiment was undertaken to ascertain
whether plasma cyt c levels are an accurate reflection of
the extent of glycerol-induced tissue damage. Eight mice
were anesthetized and injected with glycerol as noted
above, with the exception that the glycerol dose was var-
ied to produce gradations in the severity of tissue injury
and resultant ARF (6 mL/kg; 7 mL/kg; 8 mL/kg; 11 mL/kg;
N = 2 each). Eighteen hours later, BUN levels were de-
termined, and then plasma samples were subjected to
Western blotting for cyt c. To facilitate quantitation, a
relatively small amount of plasma (3 lL) was applied so
as not to ‘swamp out’ the ECL signal. Two normal plasma
samples were included, serving as control samples. A cor-
relation between post-glycerol BUN and cyt c levels was
sought (excluding the normal plasma samples from this
analysis).
Isolated proximal tubule segment (PTS) experiments
The following experiments were conducted to deter-
mine some of the cellular determinants of cyt c release.
Tubule isolation. Proximal tubules were isolated from
normal CD-1 male mice (25 to 35 g; Charles River,
Wilmington, MA, USA) as previously described [11, 16].
They were suspended in an experimentation buffer (in
mmol/L: NaCl, 100; KCl, 2.1; NaHCO3 25; KH2PO4, 2.4;
MgSO4 1.2; MgCl2, 1.2; CaCl2 1.2; glucose 5; alanine 1;
Na lactate 4; Na butyrate 10; 36-kD dextran, 0.6%; gassed
with 95% O2/5% CO2; final pH 7.4) to a tubule protein
concentration of 2 to 4 mg/mL. Each PTS preparation
was rewarmed to 37◦C, divided into 2 to 5 equal aliquots
(1.25 mL) depending on the experiment, placed into
10-mL Erlenmeyer flasks, and used in individual experi-
ments, as detailed below.
Cyt c release with mitochondrial inhibition: Hypoxia
vs. antimycin a effects
The following experiment was conducted to ascer-
tain whether inhibition of the mitochondrial respiratory
chain, with resultant ATP depletion injury, leads to extra-
cellular cyt c release. To ascertain whether cyt c release
was dependent on plasma membrane disruption, the lat-
ter was prevented by glycine addition [17, 18]. To achieve
these ends, 4 sets of PTS were divided into 5 aliquots
and incubated for 20 minutes under one of the following
conditions: (1) control incubation (95% O2/5% CO2);
(2) incubation under hypoxic conditions (95% N2/5%
CO2); (3) incubation with antimycin A (AA; 100 lmol/L;
dissolved in ethanol, final concentration, 0.5%); (4) hy-
poxic incubation + 2 mmol/L glycine; and (5) incuba-
tion with AA + 2 mmol/L glycine. After completing the
20-minute incubations, lethal cell injury was assessed by
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% lactate dehydrogenase (LDH) release. Total PTS sus-
pension protein was assessed, the tubule preparations
were then centrifuged, and the remaining protein in the
supernatant was determined. Protein levels were deter-
mined by the bichinoninic acid method (Pierce Chemi-
cals, Rockford, IL, USA). The remainder of suspending
medium samples were stored at −20◦C for subsequent
cyt c Western blotting, as detailed below [11].
Rotenone vs. antimycin a-induced cytochrome c release
The above experiments suggested that different sites of
mitochondrial inhibition (site 3 with hypoxia; site 2 with
AA) have differential effects on cyt c release. To further
explore this issue, the relative effects of a site 1 (rotenone;
Rot) versus site 2 (AA) inhibition on cyt c release in the
presence or absence of glycine were compared. To this
end, 4 sets of mouse tubules were each divided into 5
aliquots as follows: (1) control incubation; (2) 100 lmol/L
AA; (3) AA + 2 mmol/L glycine; (4) 100 lmol/L Rot (in
0.5% ethanol); and (5) Rot + glycine. After 20-minute
incubations, % LDH release was determined, the tubules
were centrifuged, and a sample of suspending medium
was saved for cyt c Western blot.
Fe-mediated oxidative stress
Because the test in vivo system used in this study,
glycerol-induced rhabdomyolysis, has a major pathogenic
component of Fe-mediated injury (e.g., references [16,
19–22]), the impact of Fe-induced oxidative stress on
tubule cyt c release was assessed. For the sake of com-
parison, the effect of Fe was contrasted with that of AA
(which induced the greatest degree of cyt c release in
the above noted experiments; see Results). Four sets of
PTS were prepared and each was divided into 3 aliquots:
(1) control incubation; (2) incubation with 25 lmol/L fer-
rous ammonium sulfate (Fe), complexed to equimolar
hydroxyquinoline (HQ) (an iron siderophore allowing
for intracellular Fe access; FeHQ reference [23]); and (3)
100 lmol/L AA. After completing 20-minute incubations,
aliquots from each flask were removed for assessment of
lethal cell injury (% LDH release). Tubule medium was
saved for detection of cyt c.
Assessment of total cellular cyt c loss during acute
cell injury
The above experiments ascertained degrees of cyt c
efflux into the extracellular space (i.e., tubule suspend-
ing medium after centrifugation). However, the degree
to which mitochondrial/cellular cyt c depletion occurred
could not be assessed. To gain insights into this issue, PTS
were prepared and subjected to either control incubation
(N = 9), or to the hypoxic (N = 3), Fe (N = 3), or AA chal-
lenges (N = 3) × 20 minutes. At the completion of the in-
cubations, the tubules were pelleted by centrifugation and
then lysed (see below; Western blotting method). The sol-
ubilized material was then centrifuged to remove residual
insoluble debris, and the remaining solubilized samples
were subjected to Western blotting. Relative amounts of
cell cyt c loss was assessed by comparing amounts of cyt c
in the normal centrifuged tubule extracts versus the cen-
trifuged extracts from tubules which had undergone the
above challenges.
Effects of treatments on proximal tubule ATP levels
The question emerged as to whether differences in cyt
c release corresponds to degrees of mitochondrial block-
ade/ATP depletion. To address this issue, tubule aliquots
were collected during each of the above-performed ex-
periments, and extracted in cold 6.66% trichloroacetic
acid [24]. The recovered adenine nucleotides were then
quantified by high-performance liquid chromatography
(HPLC), as previously described [24]. Degrees of mito-
chondrial inhibition were gauged by degrees of reduction
in ATP/ADP ratios [25]. The following groups were as-
sessed: (1) control; (2) AA ± glycine; (3) Rot. ± glycine;
and (4) FeHQ ± glycine (N, 4 to 8 per group).
Impact of cholesterol oxidation on cellular cyt c release
The above experiments demonstrated that the great-
est mitochondrial/cellular cyt c loss occurred with the
Fe-mediated oxidant challenge. To ascertain whether
cholesterol oxidation might be relevant to mitochon-
drial/cell cyt c release, the following experiment was
performed. Four sets of tubules were divided into two
aliquots: (1) control incubation × 30 minutes; or (2) in-
cubation with 4 U/mL of cholesterol oxidase (C-9281;
Sigma Chemical Co., St. Louis, MO, USA) [26]. At the
completion of the incubations, % LDH release was de-
termined, and then both tubule pellet and supernatant
cyt c levels were ascertained.
Potential utility of urinary cyt c as a marker
of tissue injury
Mice: Glycerol-induced ARF. Because tissue injury
leads to increases in plasma cyt c (which should be read-
ily filterable by the glomerulus, given a 15,000 MW), and
given that injured tubules can release cyt c (see above),
the following experiment tested whether cyt c could be
detected in urine after in vivo tissue injury, thereby serv-
ing as a sign of mitochondrial/tissue damage. Three mice
were subjected to glycerol-induced ARF (8 mL/kg) as
noted above, and 18 hours later a ‘spot’ urine sample was
obtained from each animal. Severe ARF was confirmed
in these 3 mice by 18-hour BUN concentrations (157, 160,
170 mg/dL). Ten-lL samples of each of these 3 urine sam-
ples were then subjected to cyt c Western blot analysis.
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Spot urine sample obtained from 3 normal mice were si-
multaneously probed for cyt c, serving as control animals.
Mice: Postischemic ARF. The following experiment
was undertaken to ascertain whether renal specific injury,
independent of muscle necrosis (as induced by glycerol),
causes an increase in urinary cyt c excretion. Three mice
were anesthetized with pentobarbital (4 to 5 mg i.p. in-
jection), they were placed on a heated board to maintain
a 37◦C body temperature, the abdominal cavities were
opened through midline abdominal incisions, and then bi-
lateral renal pedicle occlusion was induced in each mouse
with nontraumatic microvascular clamps. After 15 min-
utes of renal ischemia, the clamps were removed, renal
reperfusion was confirmed by loss of tissue cyanosis, and
then the abdominal cavities were sutured in two layers.
The mice were allowed to recover from anesthesia, and
they were provided with free food and water access. Af-
ter an 18-hour recovery period, they were reanesthetized
with pentobarbital, and the abdominal cavities were re-
opened. Urine was expressed from the urinary bladder
and saved for Western blotting. The mice were then sac-
rificed by phlebotomy from the inferior vena cava, and
the blood samples were used to determine BUN concen-
trations. Three mice treated in an identical fashion, except
for performing sham renal pedicle occlusions, provided
control urinary and terminal blood samples.
Humans. To ascertain the potential clinical utility of
urinary cyt c levels as a marker of tissue injury, spot urine
samples were obtained from 3 patients who were diag-
nosed by nephrology consultants as having acute tubular
necrosis (ATN)-induced ARF (compatible clinical histo-
ries, supportive urinalysis findings of “ATN” casts; serum
creatinines of 2.4, 3.4, and 4.6 mg/dL). After centrifuga-
tion to remove cellular debris, 10 lL samples from each
patient sample were subjected to Western blot analysis.
Three spot urine samples obtained from normal human
subjects served as control samples.
Western blotting for cytochrome c
Proximal tubule analyses. Supernatant samples ap-
plied for Western blotting were equalized by the amount
of total cellular mass in each tubule aliquot, as assessed by
the previously determined uncentrifuged tubule aliquot
total protein content. Then, equivalent samples (based
on starting protein of the tubule suspension) were added
to sample application reagent provided for use with the
NuPAGE 12% Novex Bis Tris gel Western blotting kit
(Invitrogen, Carlsbad, CA, USA). In the case of tubule
pellets, the cells were lysed in a lysis buffer (1% Triton
X-100; 10% glycerol; 20 mmol/L HEPES pH 7.2,
100 mmol/L NaCl + protease inhibitor cocktail; Roche;
Mannheim, Germany). Then, 4 lg of the solubilized pro-
tein from the lysis buffer was applied to the Western
blotting gel. Samples were eletrophoresed and trans-
ferred to pure nitrocellulose (BioRad, Hercules, CA,
USA) membrane according to the published manufac-
turer’s instructions as specified for the utilized gel (Invit-
rogen). The samples were blocked with protein-blocking
agent (BioRad). After rinsing, the samples were probed
with a mouse monoclonal anti- cytochrome c (clone
7H8-2C12; BD PharMingen; San Diego, CA, USA). The
primary antibody was then detected by horseradish-
peroxidase–linked sheep antimouse IgG (Amersham;
Buckinghamshire, England). After rinsing, the latter was
detected by ECL (Amersham). A protein ladder was run
simultaneously with each gel. Specificity for cyt c was
determined by its appearance at the relevant molecular
weight size (15,000 d), and the absence of the relevant
protein band when probed with the secondary antibody
in the absence of the anti-cytochrome c primary antibody.
Equal protein transfers were confirmed by India ink pro-
tein staining.
Plasma and urine sample analyses. An identical
amount of plasma (either 3 or 10 lL, depending on the
experiment; see above) was applied for analysis. In the
case of urine samples, 10-lL urine samples of unconcen-
trated urine were applied. These samples were run and
analyzed as noted above.
Calculations and statistics
All values are presented as mean ± 1 SEM. Statisti-
cal comparisons were made by either paired (isolated
tubules) or unpaired (in vivo experiments) Student t test-
ing. If multiple comparisons were made, the Bonferroni
correction was applied.
RESULTS
Glycerol-induced rhabdomyolysis/ARF
As shown in Figure 1, a dose of 10 mg/kg of glyc-
erol induced severe ARF, as demonstrated by a 7-fold
increase in BUN concentrations. Cyt c was essentially
undetectable in normal plasma samples. However, after
glycerol treatment, dramatic increases in plasma cyt c lev-
els were seen. The Western blot reaction was specific for
cyt c, given that the relevant protein band (∼15 kD) was
not observed when the reaction was run in the absence
of the primary antibody (not shown).
Relationship between the severity of glycerol-induced
ARF and plasma cyt c levels
The Western blot analysis for the 8 post-glycerol
plasma samples is depicted in Figure 2. When the plasma
levels of cyt c from glycerol-treated mice were contrasted
with corresponding 18-hour post-glycerol BUN con-
centrations, a striking direct relationship was apparent
(r, 0.93; P < 0.001). The two normal plasma samples man-
ifested essentially undetectable cyt c levels (one sample
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Fig. 1. BUN concentrations and plasma cyt c levels 18 hours after
glycerol-induced acute renal failure. Glycerol (G) caused severe ARF,
as denoted by marked BUN increments (lefthand bars) versus controls
(C). Striking plasma expression of cyt c was also apparent after glyc-
erol injection (righthand bars). Conversely, minimal or no cyt c was
observed in plasma samples obtained from sham-treated controls. Rep-
resentative blots are presented for each of the two treatment groups.
BUN, blood urea nitrogen; ARF, acute renal failure.
shown at the left of Fig. 2). The BUN corresponding to
each location of the Western blot is shown numerically
below each blot.
Cyt c loss with hypoxia and antimycin a (AA)-induced
cell injury
LDH release. % LDH release with the hypoxic and
the AA challenges are presented in the lefthand panel
of Figure 3. Both hypoxia and AA induced marked in-
creases. However, the amount achieved with hypoxia was
significantly worse than with AA (54% vs. 36%, respec-
tively; P < 0.02). Glycine addition completely blocked
both hypoxia- and AA-induced LDH release.
Total protein release. Both hypoxia and AA caused
a dramatic increase in total protein within tubule buffer
(Fig. 3, right). Also, as with the LDH release results, the
amount of total protein released was significantly greater
with hypoxia compared with AA (P < 0.01). Again, as
with the LDH release data, glycine blocked total protein
release in response to the hypoxic and AA challenges
(NS vs. control values).
Cytochrome c release. Amounts of cyt c released in
these experiments are presented in Figure 4. Despite the
fact that hypoxia induced substantially and significantly
more LDH and total protein release than did AA (as
shown in Fig. 3), AA caused ∼2× as much cyt c release
into tubule buffer as did hypoxia (∼400 density units with
AA vs. ∼200 density units with hypoxia; P < 0.01).
Despite the fact that glycine completely prevented
hypoxic- and AA-induced LDH and total protein release
(as shown in Fig. 3), it did not prevent cyt c release (Fig. 4).
In the case of hypoxia, glycine caused some diminution
(but not a normalization) of cyt c levels in tubule buffer
[(P < 0.05 vs. controls (C)]. However, in the case of AA,
glycine had virtually no impact on buffer cyt c levels.
A comparison of rotenone (Rot)- vs. AA-induced LDH
and cyt c release
As shown in the lefthand panel of Figure 5, AA and
Rot each induced marked LDH release. However, the
degree of LDH release was less severe with Rot versus
AA treatment (P < 0.01). Both AA and Rot caused sig-
nificant cyt c release (P < 0.025; Fig. 5, right). However,
the degree of cyt c increase was twice as great with AA
compared with Rot treatment (P < 0.05).
A comparison of FeHQ vs. AA-mediated cell injury
The simultaneous comparison of % LDH release and
cyt c release with AA- versus FeHQ-mediated oxidative
stress is presented in Figure 6. Despite the fact that FeHQ
caused ∼half as much lethal cell injury as did AA (42% vs.
25% LDH release; Fig. 6, left panel), FeHQ caused twice
the amount of cyt c release (Fig. 6, right panel). Indeed, if
one factors the amount of cyt c release by the amount of
cell death (% LDH release), the amount of cyt c release
was 4× higher with FeHQ versus AA treatment.
ATP/ADP ratios with cell injury protocols
As depicted in Figure 7, hypoxia, AA, and Rot each in-
duced profound suppression of ATP/ADP ratios. How-
ever, the degree of suppression was greatest with AA,
with values falling to approximately half of those ob-
served with hypoxia or Rot treatment. FeHQ caused far
less suppression of ATP/ADP ratios than any of the other
treatments. This was despite the fact that FeHQ caused
the greatest degree of cyt c release (i.e., the rank order
of cyt c release for all experiments was FeHQ >> AA >
hypoxia ∼= Rot). Not shown, the addition of glycine had
virtually no impact on ATP/ADP ratios under conditions
of hypoxic-, AA-, Rot-, or FeHQ-mediated injury.
Semiquantitation of tubule cyt c retention after
injury protocols
The amounts of cyt c remaining in tubule pellets af-
ter the hypoxic and AA challenges are depicted in the
top row of Figure 8. Only a very small cyt c decrement
was apparent in tubules after AA treatment, whereas no
decrease could be appreciated after hypoxic treatment.
[Thus, this indicates that the AA- and hypoxia-induced
cyt c release into the tubule media (vide supra) repre-
sented only a small percentage of the total cyt c content
of the cells]. In contrast, as shown in the second row of
Figure 8, the FeHQ challenge caused marked liberation
2128 Zager et al: Extracellular cytochrome c release
100
200
300
400
500
600
20 40 60 80 100 120 140 160 180 200 230
BUN
Cy
t c
, d
en
sit
y 
un
its
26 207 225 132 41 114 37 78 177
r = 0.93
Fig. 2. Correlation between BUN concentra-
tions and plasma cyt c expression after vari-
able doses of glycerol, and hence, varying
severities of ARF. BUNs 18 hours after differ-
ing doses of glycerol (see text) ranged from 37
to 225 mg/dL. The corresponding cyt c West-
ern blot for each sample is shown along the x
axis, with the corresponding BUN below each
sample. The densitometric units for cyt c are
shown along the y axis. The correlation be-
tween BUN and corresponding cyt c levels is
presented in the dot plot (r, 0.93; P < 0.001).
BUN, blood urea nitrogen; ARF, acute renal
failure.
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Fig. 3. Severity of isolated proximal tubular
cell injury after hypoxia (Hyp) or antimycin A
(AA) treatment, as reflected by % LDH re-
lease (A) and total protein release into tubule
buffer (B). Both hypoxia and AA caused
marked LDH and total protein release, com-
pared to control tubules (Control). However,
AA caused less injury than hypoxia, as as-
sessed by either injury parameter. Glycine
(Gly) was fully protective against both hy-
poxia and AA, as gauged by either LDH or to-
tal protein release (P values, unless depicted
otherwise, reflect comparisons to simultane-
ously incubated controls).
of total cyt c, with the pellet values declining by ∼65% in
comparison to the coincubated control tubules.
As shown in the third row of Figure 8, cholesterol ox-
idase (CO) caused almost complete mobilization of cyt
c release from the tubules, with virtually no cyt c being
recovered in the tubule pellets. This corresponded with
54% ± 3% LDH release (i.e., the approximate% LDH
release values induced by the hypoxic challenge used
throughout these experiments, e.g., as depicted in Fig. 3).
The cyt c that was released from tubules with CO was re-
covered in the tubule supernatants (Fig. 8, bottom row),
indicating that its loss from tubules was not caused by its
destruction by CO treatment.
Urinary cyt c levels after renal injury
Both the glycerol and ischemic injury models of renal
injury caused severe ARF, as denoted by BUN concentra-
tions of 158 ± 4 mg/dL and 129 ± 18 mg/dL, respectively
(control 30 ± 2 mg/dL; P < 0.005 vs. both injury groups).
As shown in Figure 9 (top row), urines obtained from
control mice used for the glycerol experiments had no
discernible cyt c. Conversely, after glycerol injection, a
dramatic increase in urinary cyt c was observed. Urines
from sham (S)-operated mice used as control for the is-
chemia experiments demonstrated very small amounts
of cyt c (consistent with tissue injury evinced by laparo-
tomy). However, the postischemia mice had a marked
increase in urine cyt c levels (i.e., above that observed
in their sham-operated controls) (Fig. 9, middle row). As
shown in the bottom row of Figure 9, all three patients
with a clinical diagnosis of ATN had clearly detectable
urinary cyt c. No cyt c was apparent in control human
urine samples.
DISCUSSION
Mitochondrial cyt c release is widely recognized as an
initiator of the intrinsic apoptotic pathway. However, af-
ter its participation in apoptosome formation and cas-
pase activation, little is known of its fate. Recent cell
culture studies utilizing Jurkat T cells and mouse fibrob-
lasts found that, after the induction of apoptosis, cyt c is
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Fig. 4. Comparison of cyt c release into tubule medium after hypoxia
(Hyp) or antimycin A (AA) treatment ± glycine (Gly) to prevent
plasma membrane disruption. Hypoxia caused modest cyt c efflux [P <
0.01 vs. controls; control (C)]. Gly decreased, but did not block, hypoxia-
mediated cyt c release. In contrast, AA caused dramatic cyt c release
(∼2× hypoxic values), and Gly did not diminish this result.
rapidly released into the extracellular space [12]. Con-
versely, with cell necrosis, cyt c efflux did not occur [12].
These findings led to the further conclusion that rapid
cyt c release into the extracellular space is an ‘apoptosis-
specific’ event. That cyt c appeared in human plasma after
cancer chemotherapy led these authors to further con-
clude that circulating cyt c levels might be a clinically
useful marker of in vivo apoptotic death.
Recent studies from this laboratory conducted using
freshly isolated mouse proximal tubules indicated that
cellular cyt c efflux occurs within minutes of their ex-
posure to ioversol, a radiographic contrast agent [11].
This change predominantly correlated with mitochon-
drial dysfunction, rather than with tubular cell death, sug-
gesting that cellular cyt c release might serve as a marker
of mitochondrial ‘stress.’ Unlike cultured Jurkat cells or
fibroblasts [12], which are highly glycolytic, freshly iso-
lated proximal tubules are almost entirely dependent on
aerobic metabolism. This indicates that extracellular cyt
c release is not specifically linked to either glycolytic or
aerobic energy metabolism. Furthermore, that cell cyt
c release can occur from epithelial cells (i.e., proximal
tubules [11]), and not simply malignant cells (or cells
of hematopoietic/mesenchymal origin [12]), implies that
this process might well be reflective of diverse forms of
tissue damage.
Unlike cancer chemotherapy, which predominantly
evokes tumor cell apoptosis, rhabdomyolysis-induced
ARF is largely a result of necrotic cell death involv-
ing both skeletal muscle and proximal tubular cells [13,
27, 28]. Hence, the present study sought to determine
whether plasma cyt c appearance might also reflect in
vivo, noncancer cell necrosis, and if so, might this change
quantitatively denote the severity of the tissue injury sus-
tained. The answers to both of these questions appears
to be yes. Not only did glycerol-induced rhabdomyoly-
sis evoke massive plasma cyt c increments (see Fig. 1),
the elevations strikingly correlated with the severity of
the tissue damage sustained, as gauged by BUN concen-
trations (r, 0.93). There are two likely explanations for
this tight relationship: First, plasma cyt c concentrations
likely reflect degrees of tissue injury (e.g., in a fashion
analogous to transaminases or creatine phosphokinase
release). Second, given its low molecular weight (15,000),
cyt c should be freely filtered by the glomerulus, thereby
serving as a surrogate marker of GFR. Hence, progres-
sive increments in tissue injury, coupled with reciprocal
decrements in GFR, would be expected to cause stepwise
plasma cyt c elevations. The relative contributions of in-
creased tissue release versus decreased urinary excretion
to this result cannot be dissected at this time with the
available data.
Rhabdomyolysis-induced renal tubular injury is
thought to arise from a combination of heme Fe-mediated
oxidant injury and ischemic tubular damage, the latter
mediated by severe renal vasoconstriction (e.g., [13, 29]).
To gain insights into the impact of these two injury path-
ways on proximal tubular cyt c efflux, freshly isolated
mouse proximal tubules were subjected to mitochondrial
respiratory chain inhibition, or to Fe-mediated oxidative
stress. A number of interesting observations arose from
these investigations. First, although AA, Rot, and hy-
poxia each caused cellular cyt c release, the extent of this
process quantitatively varied, depending on the site of
interruption of the mitochondrial respiratory chain. This
is illustrated by the fact that AA-induced site 2 inhibition
caused approximately twice as much cyt c release as either
site 1 (Rot) or site 3 (hypoxia) respiratory chain block-
ade. Second, given that profound ATP depletion (e.g.,
as induced by AA, Rot, or hypoxia) in freshly isolated
proximal tubules induces proximal tubular cell necrosis
rather than apoptosis [28], the concept that cellular cyt
c release, or for that matter, its plasma appearance, is
a specific marker of apoptosis [12] seems very much in
doubt. Rather, circulating cyt c much more likely reflects
mitochondrial dysfunction or injury, which ultimately can
induce either necrotic, or apoptotic, cell death. Third, cyt
c release is not simply a quantitative marker of the extent
of tubular cell death. This point is underscored by the fol-
lowing facts: (1) FeHQ and AA each induced comparable
degrees of proximal tubular injury/LDH release, and yet
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Fig. 5. % LDH release (A) and correspond-
ing cyt c release (B) into tubule medium fol-
lowing antimycin (AA) ± glycine or rotenone
(Rot)±glycine treatment. AA caused greater
cell death than did Rot (P < 0.01). It also
caused greater cyt c release (P < 0.05).
Whereas glycine (gly) blocked both AA- and
Rot- induced LDH release, it did not impact
the degree of cyt c release. Thus, complete
membrane permeabilization, as reflected by
LDH release, did not alter the degree to which
cyt c traversed the plasma membrane.
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Fig. 6. Comparison of LDH (A) and cyt c (B)
release induced by antimycin A (AA) or Fe
hydroxyquinoline (FeHQ). AA and Fe each
induced significant LDH release compared to
controls. However, the amount of LDH re-
lease was significantly greater with AA. In
sharp contrast, the amount of cyt c release was
twice as great with Fe than with AA. Thus,
there was an apparent dissociation between
lethal cell injury (LDH release) and cell cyt c
efflux.
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Fig. 7. Relative degrees of mitochondrial dysfunction induced by hy-
poxia (Hyp), antimycin A (AA), rotenone (Rot), or FeHQ, as assessed
by tubule ATP/ADP ratios. Hypoxia, AA, and Rot each induced pro-
found reductions in ATP/ADP ratios, although the degree was signif-
icantly greater with AA treatment (95% reductions vs. ∼90% reduc-
tions with hypoxia or rotenone). Despite the fact that FeHQ caused the
greatest degree of mitochondrial cyt c release vs. the other challenges,
Fe caused far less suppression of ATP/ADP ratios. Thus, the degree of
ATP/ADP reductions and cyt c release did not correlate.
FeHQ caused twice as much cyt c release; and (2) AA
evoked far greater cyt c release than did hypoxia, despite
the fact that hypoxia caused significantly greater tubular
cell death (54% vs. 36% LDH release).
Given that cyt c release did not correlate with the ex-
tent of cell death, an alternative hypothesis was tested:
that this process reflects degrees of mitochondrial dys-
function (e.g., as reflected by an ability to phosphory-
late ADP to ATP). To test this hypothesis, ATP/ADP
ratios were measured under conditions of AA-, Rot-, or
hypoxia-induced respiratory chain blockade. Indeed, AA
caused statistically greater ATP/ADP depressions than
did either hypoxia or rotenone (95% vs. 90% decrements,
respectively). This is consistent with the hypothesis that
degrees of cyt c release might be a surrogate marker for
the severity of an energy depletion state. However, the
results obtained with FeHQ clearly rule out this possibil-
ity. Despite the fact that the FeHQ challenge caused rela-
tively modest (∼50%) ATP/ADP reductions, it evoked by
far the greatest degree of cellular cyt c leak. Clearly then,
degrees of energy depletion, per se, cannot account for
the observed differences in cellular cyt c efflux. Rather,
it appears more likely that mitochondrial damage (e.g.,
as induced by Fe) [27], rather than electron chain block-
ade, per se (e.g., with AA, Rot, or hypoxia), impacts the
degree to which cyt c is liberated, and hence, is able to
migrate to the cytosol and ultimately to the extracellular
space.
Although each of the above challenges caused cyt c ap-
pearance in tubule buffer, the relative amount of this loss,
vis a` vis the total intracellular/mitochondrial pool, could
not be discerned. Therefore, to gain insights into this
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Fig. 8. Cyt c in tubule pellets or supernatants
after either control (C), antimycin A (AA), or
FeHQ incubations. As shown in the top row,
despite the fact that AA and hypoxia effected
cyt c efflux into tubule buffer, the majority of
total cyt c was retained within the cells (as de-
picted by blots showing minimal decreases in
cyt c retention in the remaining tubules pel-
lets). In contrast, FeHQ effected massive cell
cyt c efflux, as demonstrated by an approxi-
mate two thirds reduction in pelleted tubule
cyt c content (second row). As shown in the
third row, cholesterol oxidation, effected by
cholesterol oxidase (CO) treatment, basically
evacuated all cyt c from pelleted tubules. The
lost cyt c after CO treatment was recovered
in the tubule supernatants, thereby indicating
that the cellular cyt c loss was caused by cell
efflux, not cyt c destruction.
issue, amounts of cyt c remaining in tubules after hypoxia-,
AA-, or FeHQ-induced injuries were assessed. The Fe
challenge caused massive cyt c losses, approximating two
thirds of the total mitochondrial/cellular pool. In con-
trast, <10% to 20% of total cyt c was released from cells
in response to the AA and hypoxic challenges. Notewor-
thy in regards to these findings are the recent studies of
Scorrano et al [30]. These investigators have posited that
∼15% of total mitochondrial cyt c resides within the in-
termembrane mitochondrial space (IMS) (i.e., between
outer inner membranes). This is thought to represent a
relatively ‘labile’ pool capable of ready cytosolic access.
Conversely, the residual 85% of cyt c is within the mi-
tochondrial cristae, with this pool requiring substantial
cristae rearrangement for cyt c release to occur [30]. Thus,
when the present results are interpreted in the light of
these observations, it would appear that AA, hypoxia,
and Rot effected cyt c release from the IMS, whereas Fe
must have caused structural mitochondrial disruption in
order for massive cyt c spillage to occur. Why cyt c release
was apparently greater with AA compared with hypoxia
or Rot remains unclear at this time. While an increase
in oxidant stress with AA might explain such a result
(as suggested by the FeHQ results), we have previously
documented that AA actually decreases, rather than in-
creases, isolated tubule lipid peroxidation [31]. Thus, this
relatively simple explanation seems untenable, at least at
this time. Also of note is the possibility that differences
of cytosolic levels of cyt c could have emerged from these
treatments, and ultimately, this underlies the differences
in cell cyt c efflux. Clearly, definition of this possibility
would require extensive additional studies to evaluate
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Fig. 9. Urinary cyt c levels following glyc-
erol (G)-induced acute renal failure (ARF),
postischemic/reperfusion ARF (I/R), or clin-
ical acute tubular necrosis (ATN). As shown
in the top row, glycerol-induced ARF caused
dramatic urinary cyt c increases, compared to
control (C) mouse urine samples. I/R also in-
creased urinary cyt c levels, compared to sham
(S)-operated controls (middle row). Finally,
as shown in the third row, three patients with
ATN each had detectable cyt c in urine, com-
pared with normal (N) subjects.
simultaneous relative distributions between mitochon-
dria, cytosolic, and the extracellular pools. This would
appear to be a worthwhile goal for future investigations.
In a previous study from this laboratory, it was docu-
mented that cholesterol oxidase treatment of proximal
tubular cells leads to a profound ATP depletion state
[26]. However, the mechanism by which this occurred
remained in doubt. Given the observation that FeHQ-
induced tubule oxidation caused striking cyt c efflux,
we queried whether cholesterol oxidation, per se, might
cause, or underlie, this result. To test this possibility,
cholesterol oxidation was induced with cholesterol oxi-
dase, and indeed, unlike any other previously tested chal-
lenge, a virtual complete loss of mitochondrial/cellular
cyt c resulted. Given this observation (and hence, the re-
sultant electron chain disruption), it seems all but cer-
tain that mitochondrial cyt c displacement explains why
cholesterol oxidation evokes such a profound energy
depletion state [26]. Why cholesterol oxidase evinces
massive cyt c efflux remains uncertain at this time. One
possiblity is that with cholesterol oxidase–induced plasma
membrane damage, the enzyme is able to enter the cy-
tosol, directly attack mitochondrial cholesterol, and in
some way, untether cytochrome c, allowing for mito-
chondrial and cell efflux. Alternatively, it could be that
oxidized cholesterol within the plasma membrane cy-
cles to the mitochondria, induces injury, and then causes
cyt c release. Clearly, dissecting the specific underlying
mechanism(s) for this observation will require additional
exploration.
After mitochondrial release, cyt c must traverse the
plasma membrane to eventuate in the extracellular space.
To ascertain whether this requires complete membrane
dissolution, the latter was blocked by adding glycine to
the hypoxic, AA, or Rot challenged tubules. As pre-
viously noted by Weinberg et al [17, 18], glycine fully
prevented ATP depletion–mediated membrane perme-
abilization, as reflected by cytosolic LDH release, and
tubule total protein loss. Conversely, glycine only mod-
estly decreased hypoxia-induced cyt c efflux, and in the
case of the Rot and AA challenges, no extracellular cyt
c reductions were observed. Clearly then, once released
from mitochondria, cyt c can readily traverse the plasma
membrane in the absence of complete plasma membrane
disruption (i.e., attendant necrotic cell death). Given cyt
c’s low molecular weight (15,000) relative to that of LDH
(∼140,000), it could be that cyt c is simply able to diffuse
down its concentration gradient, thereby enriching the
extracellular space. However, because glycine has been
reported to prevent the passage of low molecular weight
dextrans (>3000 d [32]) into ATP depleted cells, it would
appear that more than simple pore size alterations may
be required for cyt c efflux to occur. What can be inferred,
however, is that active export of cyt c from the cell seems
unlikely, given that that massive cyt c efflux occurred in
the setting of severe ATP depletion states (e.g., as in-
duced by AA or hypoxia). This suggests that a passive,
rather than an active (ATP dependent), export process is
involved.
The final goal of this study was to ascertain whether
measurement of cyt c in urine might have potential utility
as a marker of acute in vivo renal mitochondrial damage.
To gain an initial insight into this issue, urine samples were
obtained from glycerol-treated mice, they were probed
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for cyt c, and dramatic increases were seen. However, to
the degree that muscle injury–induced cyt c release could
eventuate in increased urinary excretion, these positive
results left unclear whether renal injury, per se, would
culminate in increased cyt c excretion. To address this is-
sue, renal-specific injury (except for tissue trauma caused
by laparotomy) was induced by transient bilateral renal
pedicle occlusion, and 18 hours later, urine cyt c levels
were assessed. As with the glycerol model, urinary cyt
c appearance was again observed (i.e., in comparison to
sham surgery controls). Thus, this supports the possibility
that quantifying urinary cyt c might prove to be a poten-
tially useful marker of acute renal injury, in general, and
of tubular mitochondrial injury, in particular. That three
patients, judged to have acute tubular necrosis, also had
elevated urinary cyt c levels provides additional support
in this regard. However, it is also clear that increased fil-
tration of circulating cyt c may be an important variable
in interpreting urine cyt c levels.
CONCLUSION
The present studies document that after acute renal
proximal tubular injury, cyt c, after mitochondrial re-
lease, gains rapid access to the extracellular space. This
process does not require either complete plasma mem-
brane disruption/permeabilization, or lethal cell injury,
at least as assessed by cytosolic LDH release. Rather, it is
more dependent on the site of mitochondrial respiratory
blockade (AA > Rot ≈ hypoxia), and/or whether oxida-
tive/structural mitochondrial injury results. Cholesterol
oxidation appears to be a particularly relevant molec-
ular determinant of this process, based on findings of
essentially complete cellular cyt c loss after cholesterol
oxidase treatment. Indeed, the loss of cyt c from the mito-
chondrial electron transport chain provides a compelling
explanation for why cholesterol oxidation can induce a
profound ATP depletion state [26]. The in vivo corre-
late of these processes is plasma cyt c appearance, which
can index the severity of tissue damage sustained. Con-
versely, urinary cyt c excretion can reflect either prox-
imal tubular injury, and/or increased renal excretion of
circulating cyt c following extrarenal tissue release. The
ultimate clinical utility of measuring circulating or uri-
nary cyt c remains to be defined. However, it is most
unlikely that it will specifically denote apoptosis, as previ-
ously suggested [12]. Rather, the available data suggest-
ing that cell cyt c efflux into the extracellular space in-
dicates functional and/or structural mitochondrial injury,
events which can culminate in either apoptotic or necrotic
cell death. Whether cyt c release into either plasma or
urine might lead to ‘down stream’ cell uptake, potentially
contributing to additional cell injury or apoptosis (e.g., in
the distal nephron following proximal tubular release)
remains an intriguing speculation at this time.
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